Press Releases

  • A Logistics and Pathway Design Study for Volition's CE Marked NuQ(TM) Triage Test has been Commenced in the Capital Region of Denmark

  • VolitionRx Limited's Triage Test Results Validated in Prospective Trial

  • VolitionRx Limited to Attend the BTIG 2017 Medical Technology, Life Sciences, and Diagnostics Conference

  • VolitionRx Limited to Present at Source Capital Group's 2nd Annual Disruptive Growth & Healthcare Conference on February 15, 2017

  • VolitionRx Limited Strengthens Team with Key Appointment to Drive Sales and Trials in Asia

  • VolitionRx Limited's Novel Cancer Diagnostic Test Achieves CE Marking as it Prepares for Launch Across Europe

  • VolitionRx Limited to Present at 9th Annual Biotech Showcase Conference

  • VolitionRx Limited to Attend Citi 2016 Global Healthcare Conference

  • VolitionRx Limited to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum 2016

  • VolitionRx Limited Announces Third Quarter 2016 Financial Results and Business Update

arrow-down arrow-left arrow-right arrow chevron-down circle-link--red circle-link close play plus